603998.SS SHH
Hunan Fangsheng Pharmaceutical Co., Ltd.
1W: -1.5%
1M: -3.6%
3M: +10.3%
YTD: -16.6%
1Y: -4.2%
3Y: +3.1%
5Y: +94.4%
¥10.36 ($1.54)
+0.10 (+0.97%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$195M
+122.7% ▲
5Y CAGR: +3.7%
Capital Expenditures
$95M
+56.7% ▲
5Y CAGR: -13.8%
Free Cash Flow
$100M
+176.3% ▲
Dividends Paid
$130M
+25.7% ▲
Buybacks
$2M
+19.1% ▲
Net Change in Cash
$114M
+156.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $54M | $70M | $277M | $187M | $250M |
| Depreciation & Amort. | $70M | $78M | $78M | $81M | $76M |
| Stock-Based Comp. | -$120K | $0 | $12M | $0 | $0 |
| Change in Working Capital | $53M | -$19M | $67M | -$201M | -$144M |
| Other Non-Cash Items | $59M | $57M | -$141M | $21M | $13M |
| Operating Cash Flow | $237M | $186M | $302M | $88M | $195M |
| — Investing Activities — | |||||
| Capital Expenditures | -$168M | -$185M | -$171M | -$219M | -$95M |
| Acquisitions (Net) | $38K | -$94M | -$32M | $2M | $23M |
| Investment Purchases | -$151M | -$283M | -$351M | -$152M | -$78M |
| Investment Sales | $142M | $197M | $253M | $158M | $99M |
| Other Investing | $2M | $135M | -$507K | $13M | $92M |
| Investing Cash Flow | -$174M | -$230M | -$301M | -$197M | $41M |
| — Financing Activities — | |||||
| Net Debt Issuance | $133M | $29M | $48M | $109M | $23M |
| Stock Repurchased | $0 | $0 | -$3M | -$2M | -$2M |
| Dividends Paid | -$51M | -$26M | -$104M | -$174M | -$130M |
| Other Financing | $37M | $4M | $202M | -$24M | -$14M |
| Financing Cash Flow | $101M | -$14M | $127M | -$92M | -$122M |
| Net Change in Cash | $164M | -$59M | $127M | -$201M | $114M |
| Cash End of Period | $315M | $257M | $383M | $182M | $296M |
| Free Cash Flow | $69M | $916K | $130M | -$131M | $100M |